Gufic Biosciences Limited

NSE:GUFICBIO.NS

485.45 (INR) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 8,066.6576,906.2087,791.5564,876.9863,577.5123,507.6963,009.6442,492.6852,021.9881,515.5161,230.1121,001.441835.651715.783628.864516.841540.943
Cost of Revenue 5,165.3873,318.2044,296.3132,577.6771,805.3261,818.2241,432.4121,231.6561,044.683828.853674.719519.595449.602369.404340.504281.079334.834
Gross Profit 2,901.273,588.0043,495.2432,299.3091,772.1861,689.4721,577.2321,261.029977.305686.663555.393481.846386.049346.379288.36235.761206.11
Gross Profit Ratio 0.360.520.4490.4710.4950.4820.5240.5060.4830.4530.4510.4810.4620.4840.4590.4560.381
Reseach & Development Expenses 54.12551.85944.28620.98920.00720.77552.88215.2866.7762.5817.313000000
General & Administrative Expenses 1,110.963880.686142.61492.02960.49567.78860.50967.10159.5538.57726.45917.76100000
Selling & Marketing Expenses 21.22559.56233.44118.57437.02617.31213.2360.9655.7337.46171.213138.54500000
SG&A 1,612.728940.248176.055110.60397.52185.173.74568.06665.28346.03897.672156.30600000
Other Expenses 21.77225.7393.9832.74428.09521.41418.3790.141.852.5331.9970.2932.499301.583249.286200.879171.915
Operating Expenses 1,612.7282,464.3012,208.7921,617.831,396.3631,269.1051,238.5791,026.348812.064578.037458.417386.974333.718301.583249.286200.879171.915
Operating Income 1,288.5421,153.3091,290.999676.53385.399413.437338.653173.997108.30660.64557.60149.70326.17623.70416.93617.17615.611
Operating Income Ratio 0.160.1670.1660.1390.1080.1180.1130.070.0540.040.0470.050.0310.0330.0270.0330.029
Total Other Income Expenses Net -131.827-86.1-22.616-99.415-84.137-59.947-43.246-54.507-52.655-38.892-32.904-34.44-22.63-21.091-22.138-17.706-18.584
Income Before Tax 1,156.7151,067.2091,268.383577.115303.301353.491295.407180.174111.9165.25962.73452.63129.70123.70416.93617.17615.611
Income Before Tax Ratio 0.1430.1550.1630.1180.0850.1010.0980.0720.0550.0430.0510.0530.0360.0330.0270.0330.029
Income Tax Expense 295.36270.161309.982134.79974.734134.084135.1966.03938.66723.68520.09119.33914.439.0644.6588.8126.84
Net Income 861.355797.048958.401442.316226.879219.407160.217114.13573.24341.57442.64333.29215.27114.64112.2788.3648.771
Net Income Ratio 0.1070.1150.1230.0910.0630.0630.0530.0460.0360.0270.0350.0330.0180.020.020.0160.016
EPS 8.748.229.894.562.342.822.061.170.950.540.550.430.20.190.160.110.11
EPS Diluted 8.748.229.894.562.342.822.061.170.950.540.550.430.20.190.160.110.11
EBITDA 1,458.7141,372.2521,473.912857.474506.668499.357409.233279.075202.146148.009126.315107.36271.14362.86255.69943.53552.231
EBITDA Ratio 0.1810.1990.1890.1760.1420.1420.1360.1120.10.0980.1030.1070.0850.0880.0890.0840.097